H.R. 5573 - PRICED Act
- Sponsor:
- Janice D. Schakowsky
- Summary:
- To amend the Public Health Service Act to shorten the exclusivity period for brand name biological products from 12 to 7 years. (by CRS)
- Status:
- The bill has been referred to committee.
PRICED Act
H.R. 5573 — 114th Congress (2015–2016)
- Summary
- To amend the Public Health Service Act to shorten the exclusivity period for brand name biological products from 12 to 7 years. (by CRS)
- Learn More
- At OpenCongress
- Title
- To amend the Public Health Service Act to shorten the exclusivity period for brand name biological products from 12 to 7 years.
- Other Titles
- Price Relief, Innovation, and Competition for Essential Drugs Act
- PRICED Act
- PRICED Act
- Sponsor
- Janice D. Schakowsky
- Co-Sponsors
- Subjects
- Health
- Drug safety, medical device, and laboratory regulation
- Licensing and registrations
- Marketing and advertising
- Related Bills
- Major Actions
Introduced 6/23/2016 Referred to Committee - Bill History
-
There have been no votes on this bill.
Action Date Description Introduced 6/23/2016 6/23/2016 Referred to the House Committee on Energy and Commerce. 6/23/2016 Introduced in House Number Sponsor Date Offered Status
Total contributions given to House members from interest groups that…
supported this bill
Elderly issues/Social Security | $92,561 |
Consumer groups | $30,400 |
$122,961 |
opposed this bill
Biotech products & research | $1,211,789 |
$1,211,789 |
Interest groups that opposed this bill gave 9.9 times as much as interest groups that supported this bill
Contributions data source: OpenSecrets.org